We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current CLPBY market cap is 1.37B. The company's latest EPS is USD 9.34 and P/E is 41.07.
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Revenue | 6.93B | 6.96B | 6.96B | 7.04B | 7.08B |
| Operating Income | 1.89B | 1.92B | 1.97B | 1.85B | 1.82B |
| Net Income | 912M | 805M | 875M | 1.4B | -971M |
| Year End September 30 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Revenue | 19.43B | 22.58B | 24.5B | 27.03B | 27.87B |
| Operating Income | 6.36B | 6.92B | 6.85B | 7.31B | 7.72B |
| Net Income | 4.83B | 4.71B | 4.78B | 5.05B | 3.64B |
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Assets | 49.15B | 47.88B | 48.37B | 48.8B | 46.65B |
| Total Liabilities | 32.21B | 31.43B | 32.25B | 34.99B | 33.81B |
| Total Equity | 16.94B | 16.45B | 16.12B | 13.8B | 12.84B |
| Year End September 30 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Total Assets | 15.84B | 37.45B | 48.16B | 48.07B | 48.37B |
| Total Liabilities | 7.67B | 29.15B | 30.86B | 30.13B | 32.25B |
| Total Equity | 8.17B | 8.29B | 17.3B | 17.94B | 16.12B |
| Quarter End | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Operating | 742M | 1.63B | 2.27B | 2.23B | 1.47B |
| Investing | -309M | -419M | -390M | -412M | -612M |
| Financing | -598M | -1.18B | -1.64B | -1.64B | -934M |
| Year End September 30 2025 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | DKK (kr) | |
| Operating | 5.29B | 5.1B | 4.23B | 2.77B | 6.65B |
| Investing | -2.01B | -11.76B | -8.96B | -1.34B | -1.25B |
| Financing | -3.18B | 6.59B | 5.27B | -1.52B | -5.19B |
| Market Cap | 1.374B |
| Price to Earnings Ratio | 41.07 |
| Price to Sales Ratio | 3.08 |
| Price to Cash Ratio | 4.74 |
| Price to Book Ratio | 6.73 |
| Dividend Yield (LTM) | 5.68% |
| Shares Outstanding | 225.17M |
| Average Volume (1 week) | 466.82k |
| Average Volume (1 Month) | 451.86k |
| 52 Week Change | - |
| 52 Week High | 10.03 |
| 52 Week Low | 5.86 |
| Spread (Intraday) | 0.82 (12.37%) |
| Company Name | Coloplast AS (PK) |
| Address |
Holtedam 1-3 Humlebæk, Capital Region of Denmark 3050 |
| Website | https://www.coloplast.com |
| Industry | Medical Equipment & Supplies |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Already have an account? Sign in
Don't have an account? Sign up
By registering, I confirm I have read, understand, and agree to ADVFN's Terms and Conditions and that I am a private investor.